These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10838744)

  • 1. [Anorectics and pulmonary hypertension].
    Bíbová J; Hampl V
    Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction.
    Weir EK; Reeve HL; Huang JM; Michelakis E; Nelson DP; Hampl V; Archer SL
    Circulation; 1996 Nov; 94(9):2216-20. PubMed ID: 8901674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for potassium channels in smooth muscle cells and platelets in the etiology of primary pulmonary hypertension.
    Weir EK; Reeve HL; Johnson G; Michelakis ED; Nelson DP; Archer SL
    Chest; 1998 Sep; 114(3 Suppl):200S-204S. PubMed ID: 9741569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anorectic drugs and pulmonary hypertension from the bedside to the bench.
    Michelakis ED; Weir EK
    Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants].
    Goldstein SE; Levy Y; Shoenfeld Y
    Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexigen-related cardiopulmonary toxicity.
    Gross SB; Lepor NE
    Rev Cardiovasc Med; 2000; 1(2):80-9, 102. PubMed ID: 12457145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.
    Archer SL; Djaballah K; Humbert M; Weir KE; Fartoukh M; Dall'ava-Santucci J; Mercier JC; Simonneau G; Dinh-Xuan AT
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1061-7. PubMed ID: 9769261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminorex, dexfenfluramine, and primary pulmonary hypertension.
    Kramer MS; Lane DA
    J Clin Epidemiol; 1998 Apr; 51(4):361-4. PubMed ID: 9539893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence.
    McCann UD; Seiden LS; Rubin LJ; Ricaurte GA
    JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite suppressants and cardiac valvulopathy. Current clinical perspectives.
    Gross SB
    Adv Nurse Pract; 1999 Oct; 7(10):36-40. PubMed ID: 10808770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension as a result of drug therapy.
    Higenbottam T; Laude L; Emery C; Essener M
    Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine].
    Wolf I; Mouallem M; Farfel Z
    Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468
    [No Abstract]   [Full Text] [Related]  

  • 13. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis.
    Eddahibi S; Adnot S
    Respir Res; 2002; 3(1):9. PubMed ID: 11806844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1.
    Barman SA; Isales CM
    Pulm Pharmacol Ther; 1998; 11(2-3):183-7. PubMed ID: 9918753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenfluramine: riddle or Rosetta stone?
    Weir EK; Obreztchikova M; Hong Z
    Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced pulmonary hypertension: must history repeat itself?
    Voelkel NF
    Pulm Pharmacol; 1996 Apr; 9(2):67-8. PubMed ID: 8880947
    [No Abstract]   [Full Text] [Related]  

  • 17. Appetite-suppressant drugs and primary pulmonary hypertension.
    Fishman AP
    N Engl J Med; 1997 Feb; 336(7):511; author reply 512-3. PubMed ID: 9019650
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appetite depressants and pulmonary hypertension].
    Hellermann J; Salomon F
    Ther Umsch; 1998 Sep; 55(9):548-50. PubMed ID: 9789468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends and drug exposures in pulmonary hypertension: an American experience.
    Walker AM; Langleben D; Korelitz JJ; Rich S; Rubin LJ; Strom BL; Gonin R; Keast S; Badesch D; Barst RJ; Bourge RC; Channick R; Frost A; Gaine S; McGoon M; McLaughlin V; Murali S; Oudiz RJ; Robbins IM; Tapson V; Abenhaim L; Constantine G
    Am Heart J; 2006 Sep; 152(3):521-6. PubMed ID: 16923424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High altitude may be synergistic with pulmonary hazards of appetite control medications fenfluramine and dexfenfluramine.
    Davis WM; Waters IW
    Med Hypotheses; 1997 Dec; 49(6):509-12. PubMed ID: 9466375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.